- Why Attend?
For more than a decade, The SCRS Eagle Award has recognized outstanding leadership, professionalism, integrity, passion and dedication to advancing the clinical research profession through strong site partnerships.
The symbiotic relationship between sites and the industry stands as a cornerstone for the success of clinical research, influencing innovation and advancement within the field. It is the synergy between these organizations that cultivates invaluable experiences and insights for the most crucial member of our work — the patient.
The SCRS Eagle Award is a tribute to exceptional partnerships forged between sites and the CROs and sponsors they work with every day.
Eagle Award recipients are nominated based on criteria such as:
Dear Site Partners,
We are deeply honored to be this year’s recipient of the Society for Clinical Research Sites (SCRS) Eagle Sponsor of Choice Award for the second year in a row. This award celebrates great partnerships between sites and sponsors they work with every day across the globe.
Clinical research is the foundation for developing new therapies for patients. Without dedicated research sites and staff we are unable to achieve our societal goals. On behalf of all sponsors, and particularly our company, we dedicate this award to all of the patients, sites, staff, Institutional Review Boards, partners, nurses, clinical research associates and so many others who work tirelessly to meet our collective goals. We all work together to ensure that “No Patient Is Left Behind.”
Thank you for your partnership!
Senior Vice President & Head, Global Clinical Trial Operations
Dear Site Partners:
Parexel is extremely grateful and deeply honored to receive the 2023 Society of Clinical Research Sites Eagle Award for the first time. To those who voted for us, we thank you for your support. An unwavering commitment to and collaboration with sites is instrumental in our efforts to keep patients at the heart of everything we do. Without sites, we could not do what we do, and therefore the feedback from all sites is critically important.
We know that there is much more work to be done and look forward to our continued collaboration to improve the clinical research process for the benefit of patients around the world.
President, Global Clinical and Data Operations
EVP, Head of Launch Excellence & Chief Drug Development Officer